National HealthCare CFO sells 6,813 shares

NHC’s CFO sold 6,813 common shares on September 11, 2026 and continues to hold shares plus multiple stock option awards.

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP (NHC) reported that Senior Vice President and Chief Financial Officer Brian F. Kidd sold 6,813 shares of common stock on September 11, 2026 in an open-market or private transaction at $225.70 per share, leaving him with 23,183 common shares held directly. He also reports directly held options to purchase common stock with exercise prices of $53.94 (4,147 underlying shares, expiring March 8, 2028), $94.10 (4,000 shares, expiring March 5, 2029), $90.62 (9,000 shares, expiring February 24, 2030), and $157.13 (14,000 shares, expiring February 23, 2031). No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Seller: 6,813 shares

Net Sell 5 txns

Insider KIDD BRIAN F

Role SVP, CFO

Sold 6,813 shs ($1.54M)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,813	$225.70	$1.54M
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Common Stock — 23,183 shares (Direct); Option to Purchase Common Stock — 31,147 contracts (Direct)

Key Figures

Common shares sold: 6,813 shares Sale price per share: $225.70 per share Common shares held after transaction: 23,183 shares +4 more

7 metrics

Common shares sold 6,813 shares Sale of NHC common stock by CFO on September 11, 2026

Sale price per share $225.70 per share Price for 6,813 NHC common shares sold on September 11, 2026

Common shares held after transaction 23,183 shares Direct holdings of NHC common stock by CFO after the sale

Option exercise price $53.94 Option to purchase 4,147 NHC underlying shares, expiring March 8, 2028

Option exercise price $94.10 Option to purchase 4,000 NHC underlying shares, expiring March 5, 2029

Option exercise price $90.62 Option to purchase 9,000 NHC underlying shares, expiring February 24, 2030

Option exercise price $157.13 Option to purchase 14,000 NHC underlying shares, expiring February 23, 2031

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHC’s CFO report on this Form 4?

Brian F. Kidd, NHC’s Senior Vice President and Chief Financial Officer, reported selling 6,813 shares of common stock on September 11, 2026 in an open-market or private transaction at a price of $225.70 per share.

How many NHC shares does the CFO hold after the September 11, 2026 sale?

After the September 11, 2026 sale, Brian F. Kidd holds 23,183 shares of NATIONAL HEALTHCARE CORP common stock in a direct ownership capacity, as reported in the Form 4.

Were the NHC CFO’s September 2026 stock sales under a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 trading plan affirmation box is not checked, so the reported September 11, 2026 sale of 6,813 shares was not identified as being made under a Rule 10b5-1 plan.

What stock options on NHC common stock does the CFO report holding?

Brian F. Kidd reports directly held options to purchase NHC common stock with exercise prices of $53.94 (4,147 underlying shares), $94.10 (4,000 shares), $90.62 (9,000 shares), and $157.13 (14,000 shares), expiring between March 8, 2028 and February 23, 2031.

What was the sale price for the NHC CFO’s September 11, 2026 transaction?

The September 11, 2026 sale by NHC’s CFO of 6,813 common shares was reported at a price of $225.70 per share in an open-market or private transaction.

Does the NHC Form 4 show any recent option exercises by the CFO?

No option exercises are reported. The Form 4 lists the CFO’s outstanding options to purchase NHC common stock, with specified exercise prices and expiration dates, but does not show any option exercises on September 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:21 PM Accepted by SEC EDGAR 09/14/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIDD BRIAN F

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		S		6,813	D	$225.7	23,183	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	4,147		4,147	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	4,000		4,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	9,000		9,000	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

	/s/ Brian Kidd	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)